López-Preza, F.I.; Nuñez-Lumbreras, M.d.l.A.; Sosa-Testé, I.; Fernández-Guasti, A.; Concha, L.; RodrÃguez-Obaya, T.; Rocha, L.
Subchronic Intranasal Administration of NeuroEPO Reduces Long-Term Consequences of Severe Traumatic Brain Injury in Male Rats. Antioxidants 2025, 14, 710.
https://doi.org/10.3390/antiox14060710
AMA Style
López-Preza FI, Nuñez-Lumbreras MdlA, Sosa-Testé I, Fernández-Guasti A, Concha L, RodrÃguez-Obaya T, Rocha L.
Subchronic Intranasal Administration of NeuroEPO Reduces Long-Term Consequences of Severe Traumatic Brain Injury in Male Rats. Antioxidants. 2025; 14(6):710.
https://doi.org/10.3390/antiox14060710
Chicago/Turabian Style
López-Preza, Félix Iván, Maria de los Angeles Nuñez-Lumbreras, Iliana Sosa-Testé, Alonso Fernández-Guasti, Luis Concha, Teresita RodrÃguez-Obaya, and Luisa Rocha.
2025. "Subchronic Intranasal Administration of NeuroEPO Reduces Long-Term Consequences of Severe Traumatic Brain Injury in Male Rats" Antioxidants 14, no. 6: 710.
https://doi.org/10.3390/antiox14060710
APA Style
López-Preza, F. I., Nuñez-Lumbreras, M. d. l. A., Sosa-Testé, I., Fernández-Guasti, A., Concha, L., RodrÃguez-Obaya, T., & Rocha, L.
(2025). Subchronic Intranasal Administration of NeuroEPO Reduces Long-Term Consequences of Severe Traumatic Brain Injury in Male Rats. Antioxidants, 14(6), 710.
https://doi.org/10.3390/antiox14060710
